NEW YORK (GenomeWeb News) — PerkinElmer has extended by three years a deal with Schering-Plough to implement its OneSource technology at four of the drug maker’s labs in New Jersey.
 
The deal extends a previous instrument, service, and lab-management agreement between the two companies.
 
Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.